Tag: ETFMG Treatments Testing and Advancements ETF

ETFMG Adds Biotech to their Thematic ETF Lineup with GERM

SUMMIT, N.J.–(June 18, 2020) — ETFMG, a leading thematic ETF issuer, announced today the launch of its latest innovative exchange traded fund, the ETFMG Treatments, Testing and Advancements ETF (NYSE Arca: GERM). GERM seeks to answer investor demand for direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases…. Read more »